Inhalable resveratrol microparticles produced by vibrational atomization spray drying for treating pulmonary arterial hypertension

Journal of Drug Delivery Science and Technology

Volumn 29, Issue , 2015, Pages 152-158

  Dimer, Frantiescoli A ^a   Ortiz, Manoel ^a   Pohlmann, Adriana R ^a   Guterres, Silvia S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Dry powder inhaler; Pulmonary arterial hypertension; Resveratrol; Spray dryer; Vibrational atomization

Indexed keywords

DEOXYCHOLATE SODIUM; POLYCAPROLACTONE; RESVERATROL; TREHALOSE;

AERODYNAMICS; AEROSOL; ARTICLE; BRONCHUS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRY POWDER INHALER; DYNAMICS; IN VITRO STUDY; LASER DIFFRACTION; LUNG; LUNG ALVEOLUS; MOISTURE; NEBULIZATION; PARTICLE SIZE; PULMONARY HYPERTENSION; SPRAY DRYING; SUSTAINED DRUG RELEASE; VIBRATION;

EID: 84942305202     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2015.07.008     Document Type: Article

References (40)

1. E. Kassem, T. Humpl, M.K. Friedberg, Prognostic significance of 2-dimensional, M-mode, and Doppler echo indices of right ventricular function in children with pulmonary arterial hypertension, Am. Heart J. 165 (2013) 1024-1031.
2. A. Saigal, W.K. Ng, R.B. Tan, S.Y. Chan, Development of controlled release inhalable polymeric microspheres for treatment of pulmonary hypertension, Int. J. Pharm. 450 (2013) 114-122.
3. N. Galié, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, L.J. Rubin, G. Simonneau, Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology, Eur. Heart J. 25 (2004) 2243-2278.
4. M. Smola, T. Vandamme, A. Sokolowski, Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases, Int. J. Nanomed. 3 (2008) 1-19.
5. S.E. Baker, R.H. Hockman, Inhaled iloprost in pulmonary arterial hypertension, Ann. Pharmacother. 39 (2005) 1265-1274.
6. L.J. Rose-Jones, V.V. McLaughlin, Pulmonary hypertension: types and treatments, Curr. Cardiol. Rev. 11 (2015) 73-79.
7. M.B. Chougule, B.K. Padhi, A. Misra, Nano-liposomal dry powder inhaler of amiloride hydrochloride, J. Nanosci. Nanotechnol. 6 (2006) 3001-3009.
8. S. Naikwade, A. Bajaj, P. Gurav, M. Gatne, P. Singh Soni, Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study, AAPS PharmSciTech 10 (2009) 993-1012.
9. C.B. Detoni, G.D. Souto, A.L.M. da Silva, A.R. Pohlmann, S.S. Guterres, Photostability and skin penetration of different e-resveratrol-loaded supramolecular structures, Photochem. Photobiol. 88 (2012) 913-921.
10. Y. Wang, P. Li, L. Kong, Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery, AAPS PharmSciTech 14 (2013) 585-592.
11. M.C. Fontana, T.L. Durli, A.R. Pohlmann, S.S. Guterres, R.C.R. Beck, Polymeric controlled release inhalable powder produced by vibrational spray-drying: one-step preparation and in vitro lung deposition, Powder Technol. 258 (2014) 49-59.
12. K. Schmid, C. Arpagaus, W. Friess, Evaluation of the nano spray dryer B-90 for pharmaceutical applications, Pharm. Dev. Technol. 16 (2011) 287-294.
13. T. Zhang, B.-B. Youan, Analysis of process parameters affecting spray-dried oily core nanocapsules using factorial design, AAPS PharmSciTech 11 (2010) 1422-1431.
14. F.A. Dimer, T.L. Durli, M.C. Fontana, A.R. Pohlmann, R.C.R. Beck, S.S. Guterres, Piezoelectric atomizing spray-dryer to convert liquids to dry powders: operational parameters and formulation characteristics, in: H.T. Tran, G. Pillai (Eds.), Advances in Nanotechnology & Applictions, vol. IV, CreateSpace Independent Publishing Platform, 2012, pp. 105-116.
15. T.C. Beber, D.F. Andrade, B. Kann, M.C. Fontana, K. Coradini, M. Windbergs, R.C.R. Beck, Submicron polymeric particles prepared by vibrational spraydrying: semisolid formulation and skin penetration/permeation studies, Eur. J. Pharm. Biopharm. 88 (2014) 602-613.
16. X. Li, N. Anton, C. Arpagaus, F. Belleteix, T.F. Vandamme, Nanoparticles by spray drying using innovative new technology: the Büchi nano spray dryer B- 90, J. Control Release 147 (2010) 304-310.
17. T.L. Durli, F.A. Dimer, M.C. Fontana, A.R. Pohlmann, R.C. Beck, S.S. Guterres, Innovative approach to produce submicron drug particles by vibrational atomization spray drying: influence of the type of solvent and surfactant, Drug Dev. Ind. Pharm. 40 (2014) 1011-1020.
18. C. Chun, W. Yang, C. Xueding, Z. Qi, H. Xiaoying, X. Honglei, Y. Fangyou, C. Chan, L. Yuanyuan, Z. Weixi, Y. Dan, Z. Zhoucang, Y. Lehe, D. Cheng, W. Liangxing, Resveratrol downregulates acute pulmonary thromboembolism-induced pulmonary artery hypertension via p38 mitogenactivated protein kinase and monocyte chemoattractant protein-1 signaling in rats, Life Sci. 90 (2012) 721-727.
19. A. Csiszar, N. Labinskyy, S. Olson, J.T. Pinto, S. Gupte, J.M. Wu, F. Hu, P. Ballabh, A. Podlutsky, G. Losonczy, R. de Cabo, R. Mathew, M.S. Wolin, Z. Ungvari, Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats, Hypertension 54 (2009) 668-675.
20. G. Sener, N. Topaloglu, A.O. Sehirli, F. Ercan, N. Gedik, Resveratrol alleviates bleomycin-induced lung injury in rats, Pulm. Pharmacol. Ther. 20 (2007) 642-649.
21. S. Rimbaud, M. Ruiz, J. Piquereau, P. Mateo, D. Fortin, V. Veksler, A. Garnier, R. Ventura-Clapier, Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure, PLoS One 6 (2011) 18.
22. C.-F. Hung, J.-K. Chen, M.-H. Liao, H.-M. Lo, J.-Y. Fang, Development and evaluation of emulsion-liposome blends for resveratrol delivery, J. Nanosci. Nanotechnol. 6 (2006) 2950-2958.
23. H.-C. Wang, W. John, Particle density correction for the aerodynamic particle sizer, Aerosol Sci. Technol. 6 (1987) 191-198.
24. F. Podczeck, Optimization of the operation conditions of an Andersen-Cascade impactor and the relationship to centrifugal adhesion measurements to aid the development of dry powder inhalations, Int. J. Pharm. 149 (1997) 51-61.
25. F. Podczeck, Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or mean residence time (MRT), Int. J. Pharm. 97 (1993) 93-100.
26. A.R. Pohlmann, F.N. Fonseca, K. Paese, C.B. Detoni, K. Coradini, R.C. Beck, S.S. Guterres, Poly(ε-caprolactone) microcapsules and nanocapsules in drug delivery, Expert Opin. Drug Deliv. 10 (2013) 623-638.
27. M. Adler, M. Unger, G. Lee, Surface composition of spray-dried particles of bovine serum albumin/trehalose/surfactant, Pharm. Res. 17 (2000) 863-870.
28. O.N. Ogáin, J. Li, L. Tajber, O.I. Corrigan, A.M. Healy, Particle engineering of materials for oral inhalation by dry powder inhalers. Idparticles of sugar excipients (trehalose and raffinose) for protein delivery, Int. J. Pharm. 405 (2011) 23-35.
29. X. Li, H. Mansour, Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery, AAPS PharmSciTech 12 (2011) 1420-1430.
30. S.H. Lee, D. Heng, W.K. Ng, H.-K. Chan, R.B.H. Tan, Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy, Int. J. Pharm. 403 (2011) 192-200.
31. S. Ohtake, R.A. Martin, L. Yee, D. Chen, D.D. Kristensen, D. Lechuga-Ballesteros, V. Truong-Le, Heat-stable measles vaccine produced by spray drying, Vaccine 28 (2010) 1275-1284.
32. I. Zbicinski, A. Delag, C. Strumillo, J. Adamiec, Advanced experimental analysis of drying kinetics in spray drying, Chem. Eng. J. 86 (2002) 207-216.
33. M. Ortiz, D. Jornada, A. Pohlmann, S. Guterres, Development of novel chitosan microcapsules for pulmonary delivery of dapsone: characterization, aerosol performance, and in vivo toxicity evaluation, AAPS PharmSciTech (2015) 1-8.
34. D.A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, M.L. Eskew, J. Mintzes, D. Deaver, N. Lotan, R. Langer, Large porous particles for pulmonary drug delivery, Science 276 (1997) 1868-1872.
35. R.C.R. Beck, A.R. Pohlmann, C. Hoffmeister, M.R. Gallas, E. Collnot, U.F. Schaefer, S.S. Guterres, C.M. Lehr, Dexamethasone-loaded nanoparticlecoated microparticles: correlation between in vitro drug release and drug transport across caco-2 cell monolayers, Eur. J. Pharm. Biopharm. 67 (2007) 18-30.
36. G. Szakonyi, R. Zelko, The effect of water on the solid state characteristics of pharmaceutical excipients: molecular mechanisms, measurement techniques, and quality aspects of final dosage form, Int. J. Pharm. Investig. 2 (2012) 18-25.
37. M. Beck-Broichsitter, C. Schweiger, T. Schmehl, T. Gessler, W. Seeger, T. Kissel, Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery, J. Control Release 158 (2012) 329-335.
38. H.-K. Chan, Dry powder aerosol drug deliverydopportunities for colloid and surface scientists, Coll. Surf. A Physicochem. Eng. Asp. 284-285 (2006) 50-55.
39. Y. Zhang, Y.-f. Yu, X.-x. Shi, S.-c. Zhao, A.-b. Chen, D.-w. Huang, D.-j. Niu, Z. Qin, Study on the preparation of genipin crosslinked chitosan microspheres of resveratrol and in vitro release, J. Polym. Res. 20 (2013) 1-10.
40. D.Y. Arifin, L.Y. Lee, C.-H. Wang, Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems, Adv. Drug Deliv. Rev. 58 (2006) 1274-1325.